Literature DB >> 8002994

Identification of two distinct promoters in the chicken caldesmon gene.

H Yano1, K Hayashi, M Haruna, K Sobue.   

Abstract

Caldesmon (CaD) is a suitable molecular marker for phenotypic modulation of smooth muscle cells. Chicken CaD gene is composed of 17 exons with a whole length of 100-150 kilobases (kb). Exons 1a-1, 1a-2, and 1a-3 encode the 5'-terminal sequence specific to mRNA for gizzard type CaD, and exon 1b encodes the sequence specific to brain type CaD mRNA. Here, we have characterized the 5'-upstream regions of chicken CaD gene. Primer extension analysis revealed that the transcriptional starting sites of gizzard and brain CaD mRNAs were 218 and 279 nucleotides upstream from each translational initiation codon, respectively. We have identified two distinct promoters (gizzard type and brain type promoters) in the CaD gene by bacterial chloramphenicol acetyltransferase (CAT) assay using chick embryo fibroblasts (CEFs). The 5'-upstream region of exon 1a-1 showed remarkable promoter activity, but the activity of the 5'-upstream region of exon 1b was low (10% of the former). These results indicate that CaD subtypes are generated by differential RNA transcriptions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8002994     DOI: 10.1006/bbrc.1994.1746

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation.

Authors:  K Sobue; K Hayashi; W Nishida
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

Review 2.  Diversification of caldesmon-linked actin cytoskeleton in cell motility.

Authors:  Taira Mayanagi; Kenji Sobue
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

3.  A serum response factor-dependent transcriptional regulatory program identifies distinct smooth muscle cell sublineages.

Authors:  S Kim; H S Ip; M M Lu; C Clendenin; M S Parmacek
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

Review 4.  Caldesmon as a therapeutic target for proliferative vascular diseases.

Authors:  Chi-Ming Hai
Journal:  Mini Rev Med Chem       Date:  2008-10       Impact factor: 3.862

5.  A 32-nucleotide exon-splicing enhancer regulates usage of competing 5' splice sites in a differential internal exon.

Authors:  M B Humphrey; J Bryan; T A Cooper; S M Berget
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

6.  Essential role of caldesmon in the actin filament reorganization induced by glucocorticoids.

Authors:  F Castellino; S Ono; F Matsumura; A Luini
Journal:  J Cell Biol       Date:  1995-12       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.